Skip to main content
SpringerLink
Log in

Long-Term Perspective on Utility of Peritoneal Dialysis in Diabetes

  • Chapter
Diabetic Renal-Retinal Syndrome

  • 81 Accesses

Abstract

Diabetic patients are vulnerable to considerable morbidity, which has been linked to diabetic nephropathy neuropathy and retinopathy whereas, diabetic nephropathy is the most common cause of end-stage renal disease (ESRD). Early initiation of dialysis, technological improvements in renal replacement therapy, and advances in the management of coronary-artery disease and critical-care medicine, have resulted in a dramatic improvement of survival of diabetics on dialysis.

However, long-term mortality rates in diabetic patients are still twice as high as in non-diabetic dialysis patients and only a small number of diabetic dialysis patients have been followed up for more than 5 years. This is largely due to coexisting, far-advanced, target-organ damage at the initiation of dialysis and its progression during the course of dialysis, as well as to the presence of various comorbid conditions at the start of dialysis.

Survival and technique success rates in diabetic patients undergoing dialysis therapy are lower than their nondiabetic counterparts patients of comparable age, whereas survival of diabetic ESRD patients undergoing either peritoneal dialysis (PD) or hemodialysis (HD) probably is similar.

This paper was designed to describe the long-term perspective utility of peritoneal dialysis in patients with end stage renal disease patients due to diabetes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. USRDS (United States Renal Data System) USRDS 2000 Annual Data Report. Atlas of end — stage renal disease in the United States. National Institute of Health. NIDDK/DKUHD Am J Kidney Dis 2000; 36(Suppl 2): S38–S176.

    Google Scholar 

  2. Piccoli GB, Quarello F, Bonello F, et al. Diabetic patients on dialysis: a changing picture. Kidney Int 1993; 41(Suppl): S14.

    CAS  Google Scholar 

  3. Passadakis P, Oreopoulos DG. Continuous ambulatory peritoneal dialysis in 224 diabetics with end stage renal disease: evidence of improved survival over the past 10 years. In: Friedman EA, L’Esperance FA (eds), Diabetic Renal-Retinal Syndrome, 21st Century Management Now. Kluwer Academic, London, England, 1998, pp 89–115.

    Chapter  Google Scholar 

  4. Schaubel D, Fenton SSA. Diabetes and Renal Failure. Section 6. Canadian Organ Replacement Register. Annual Report 1996. Canadian Institute of Health Information, Ottawa, Ontario, 1996.

    Google Scholar 

  5. Zimmerman SW, Oxton LL, Bidwell D, Wakeen M. Long-term outcome of diabetic patients receiving peritoneal dialysis. Perit Dial Int 1996; 16: 63–68.

    PubMed  CAS  Google Scholar 

  6. Coronel F, Hortal L, Naranjo P, Pozo C, Torrente J, Prats D, Barrientos A. Analysis of factors in the prognosis of diabetics on continuous ambulatory peritoneal dialysis (CAPD): long-term experience. Perit Dial Int 1989; 9: 121–125.

    PubMed  CAS  Google Scholar 

  7. Kemperman FA, van Leusen R, van Liebergen FJ, Oosting J, Boeschoten EW, Struijk DG, Krediet RT, Arisz L. Continuous ambulatory peritoneal dialysis (CAPD) in patients with diabetic nephropathy. Neth J Med 1991 (Jun); 38: 236–245.

    PubMed  CAS  Google Scholar 

  8. Zimmerman S. The diabetic ESRD patient: specific needs. Perit Dial Int 1997; 17(Suppl 3): S9–S11.

    PubMed  Google Scholar 

  9. Tzamaloukas AH, Yuan ZY, Balaskas E, Oreopoulos DG. CAPD in end stage patients with renal disease due to diabetes mellitus — an update. In: Khanna R, Nolph KD, Prowant BF, Twardowski ZJ, Oreopoulos DG (eds), Advances in Peritoneal Dialysis, Vol 8. Peritoneal Dialysis Bulletin Inc, Toronto, 1992, pp 185–191.

    Google Scholar 

  10. Espinosa A, Cueto-Manzano AM, Velazquez-Alva C, Hernandez A, Cruz N, Zamora B, et al. Prevalence of malnutrition in Mexican CAPD diabetic and nondiabetic patients. In: Advances in Peritoneal Dialysis, Vol 12. Peritoneal Dialysis Publications, Toronto, 1996, pp 302–306.

    Google Scholar 

  11. Miller DG, Levine S, Bistrian B, D’Elia JA. Diagnosis of protein calorie malnutrition in diabetic patients on hemodialysis and peritoneal dialysis. Nephron 1983; 33: 127–132.

    Article  PubMed  CAS  Google Scholar 

  12. Viglino G, Cancarini GC, Catizone L, Cocchi R, De Vecchi A, Lupo A, Safomone M, Segoloni GP, Giangrande A. Ten years experience of CAPD in diabetics: comparison of results with non-diabetics. Nephrol Dial Transpalnt 1994; 9: 1443–1448.

    CAS  Google Scholar 

  13. Maiorca R, Vonesh E, Cancarini GC, Cantaluppi A, Manili L, Brunori G, Camerini C, Feller P, Strada A. A six-year comparison of patient and technique survivals in CAPD and HD. Kidney Int 1988; 34: 518–524.

    Article  PubMed  CAS  Google Scholar 

  14. Avram MM, Fein PA, Bonomini L, Mittman N, Loutoby R, Avram DK, Chattopadhyay J. Predictors of survival in continuous ambulatory peritoneal dialysis patients: A five-year prospective study. Perit Dial Int 1996; 16(Suppl 1): S190–S194.

    PubMed  Google Scholar 

  15. Scanziani R, Dozio B, Bonforte G, Surian M. Nutritional parameters in diabetic patients on CAPD. Adv Perit Dial 1996; 12: 280–283.

    PubMed  CAS  Google Scholar 

  16. Kriedet RT, Zuyderhoudt FMJ, Boeschoten EW, Arisz L. Peritoneal permeability to proteins in diabetic and non-diabetic continuous ambulatory peritoneal dialysis patients. Nephron 1986; 42: 133–140.

    Article  Google Scholar 

  17. Dullaart RP, Dikkeschei LD, Doorenbos H. Alterations in serum lipids and apolipoproteins in male type 1 (insulin-dependent) diabetic patients with microalbumi-nuria. Diabetologia 1989; 32: 685–689.

    PubMed  CAS  Google Scholar 

  18. Watts GF, Naumova R, Slawin BM, et al. Serum lipids and lipoproteins in insulin-dependent diabetic patients with persistent microalbuminuria. Diabetic Med 1989; 6: 25–30.

    Article  PubMed  CAS  Google Scholar 

  19. Siamopoulos KC, Elisaf MS, Bairaktari HT, Pappas MB, Sferopoulos GD, Nikolakakis NG. Lipid parameters including lipoprotein (a) in patients undergoing CAPD and hemodialysis. Perit Dial Int 1995; 15: 342–347.

    PubMed  CAS  Google Scholar 

  20. Avram MM, Goldwasser P, Burrell DE, Antignani A, Fein PA, Mittman N. The uremic dyslipidemia: a cross-sectional and longitudinal study. Am J Kidney Dis 1992; 20: 324–335.

    PubMed  CAS  Google Scholar 

  21. Lindholm B, Norbeck HE. Serum lipids and lipoproteins during continuous ambulatory peritoneal dialysis. Acta Med Scand 1986; 220: 143–151.

    Article  PubMed  CAS  Google Scholar 

  22. Burrell D, Antignani A, Fein P, Goldwasser P, Mittman N, Avram MM. Longitudinal survey of apolipoproteins and atherogenic risk in hemodialysis and continuous ambulatory peritoneal dialysis patients. ASAIO Trans 1990; 36: M331–M335.

    PubMed  CAS  Google Scholar 

  23. Little J, Phillips L, Russell L, Griffiths A, Russell GI, Davies SJ. Longitudinal lipid profiles on CAPD: their relationship to weight gain, comorbidity, and dialysis factors. J Am Soc Nephrol 1998; 9: 1931–1939.

    PubMed  CAS  Google Scholar 

  24. Assmann G, Schulte H, von Eckardstein A. Hypertriglyceridemia and elevated lipoprotein (a) are risks factors for major coronary events in middle-aged men. Am J Cardiol 1996; 77: 1179–1184.

    Article  PubMed  CAS  Google Scholar 

  25. Dahlen GH. Lp(a) lipoprotein in cardiovascular diseases. Atherosclerosis 1994; 108: 111–126.

    Article  PubMed  CAS  Google Scholar 

  26. Raitakari OT, Adams MR, Celermajer DS. Effect of Lp(a) on the early functional and structural changes of atherosclerosis. Arterioscler Thromb Vasc Biol 1999; 19: 900–905.

    Article  Google Scholar 

  27. Purnell JQ, Marcovina SM, Hokanson JE, et al. Levels of lipoprotein (a), apolipoprotein B, and lipoprotein cholesterol distribution in IDDM. Diabetes 1995; 44: 1218–1226.

    Article  PubMed  CAS  Google Scholar 

  28. Babazono T, Miyamae M, Tomonaga O, Omori Y. Cardiovascular risk factors in diabetic patients undergoing continuous ambulatory peritoneal dialysis. Advances in Peritoneal Dialysis 1996; 12: 120–125.

    PubMed  CAS  Google Scholar 

  29. Misra M, Webb AT, Reaveley DA, Doherty E, O’Donnell M, Seed M, Brown EA. The effect of change of renal replacement therapy on serum lipoprotein (a) concentration. Adv Perit Dial 1997; 13: 168–173.

    PubMed  CAS  Google Scholar 

  30. Avram MM, Sreedhara R, Patel N, Chattopadhyay J, Thu T, Fein P. Is an elevated level of serum lipoprotein (a) a risk factor for cardiovascular disease in CAPD patients? Advances in Peritoneal Dialysis 1996; 12: 266–271.

    PubMed  CAS  Google Scholar 

  31. Yang WS, Min WK, Park JS, Kim SB. Effect of increasing serum albumin on serum lipoprotein (a) concentration in patients receiving CAPD. Am J Kidney Dis 1997 (Oct); 30: 507–513.

    Article  PubMed  CAS  Google Scholar 

  32. Korbet SM, Makita Z, Firanek CA, Vlassara H. Advanced glycation end products in continuous ambulatory p peritoneal dialysis patients. Am J Kidney Dis 1993; 22: 588–594.

    PubMed  CAS  Google Scholar 

  33. Monnier VM, Sell DR, Nagarají RN, Miyata S, Grandhee S, Odetti P, Maillard. Reaction-mediated molecular damage to extracellular matirx and other tissue proteins in diabetes, aging, and uremia. Diabetes 1992; 41: 36–41.

    PubMed  CAS  Google Scholar 

  34. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complication. N Engl J Med 1988; 18: 1315–1321.

    Google Scholar 

  35. Lindblad AS, Nolph KD, Novak JW, Friedman EA. A survey of the NIH CAPD Registry population with end-stage renal disease attributed to diabetic nephropathy. J Diabetic Compl 1988; 2: 227–232.

    Article  CAS  Google Scholar 

  36. Serkes KD, Blagg CR, Nolph KD, Vonesh EF, Shapiro F. Comparison of patient and technique survival in continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis: a multicenter study. Perit Dia lnt 1990; 10: 15–19.

    CAS  Google Scholar 

  37. Gentil MA, Carriazo A, Pavon MI, et al. Comparison of survival in continuous ambulatory peritoneal dialysis and hospital haemodialysis: a multicentric study. Nephrol Dial Transplant 1991; 6: 444–451.

    PubMed  CAS  Google Scholar 

  38. Marcelli D, Spotti D, Conte F, et al. Survival ol diabetic patients on peritoneal dialysis or hemodialysis. Perit Dial Int 1996; 16: S283–S287.

    PubMed  Google Scholar 

  39. McMillan MA, Briggs JD, Junor BJ. Outcome of renal replacement treatment in patients with diabetes mellitus. BMJ 1990; 301: 540–544.

    Article  PubMed  CAS  Google Scholar 

  40. Catalano C, Goodship TH, Tapson JS, Venning MK, Taylor RM, Proud G, Tunbridge WM, Elliot RW, Ward MK, Alberti KG, et al. Renal replacement treatment for diabetic patients in Newcastle upon Tyne and the Northern region, 1964-88. BMJ 1990; 301: 535–540.

    Article  PubMed  CAS  Google Scholar 

  41. Rotellar C, Black J, Winchester JF, Rakowski TA, Mosher WF, Mazzoni MJ, Amiranzavi M, Garagusi V, Alijani MR, Argy WP. Ten years’ experience with continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1991; 17: 158–164.

    PubMed  CAS  Google Scholar 

  42. Lupo A, Tarchini R, Cancarini G, Catizone L, Cocchi R, de Vecchi A, Viglino G, Salomone M, Segoloni G, Giangrande A. Long-term outcome in continuous ambulatory peritoneal dialysis: a 10-year survey by the Italian Cooperative Peritoneal Dialysis Study Group. Am J Kidney Dis 1994; 24: 826–837.

    PubMed  CAS  Google Scholar 

  43. Rodriguez JA, Cleries M, Vela E. Diabetic patients on renal replacement therapy: analysis of Catalan Registry data. Renal Registry Committee. Nephrol Dial Transplant 1997 (Dec); 12: 2501–2509.

    Article  PubMed  CAS  Google Scholar 

  44. Zimmerman SW, Glass N, Sollinger H, Miller D, Beizer F. Treatment of end-stage diabetic nephropathy: over a decade of experience at one institution. Medicine (Baltimore) 1984; 63: 311–317.

    Article  CAS  Google Scholar 

  45. Rottembourg J, Issad B, Allouache M, Ruotolo C, Deray G, Baumelou A, Kahn JF, Jacobs C. Clinical aspects of continuous ambulatory peritoneal dialysis in diabetics Nephrologie 1988; 9: 227–232.

    PubMed  CAS  Google Scholar 

  46. Miles AM, Friedman EA. Dialytic therapy for diabetic patients with terminal renal failure. Curr Opin Nephrol Hypertens 1993; 2: 868–875.

    Article  PubMed  CAS  Google Scholar 

  47. Khanna R, Wu G, Prowant B, Jastrzebska J, Nolph KD, Oreopoulos DG. Continuous ambulatory peritoneal dialysis in diabetics with end-stage renal disease. A combined experience of two North American Centers. In: Friedman EA, L’Esperance FA (eds), Diabetic Retinal Syndrome, Vol 3. Grune and Stratton, New York, NY, 1986, pp 363–381.

    Google Scholar 

  48. Rahman EA, Wakeen M, Zimmerman SW. Characteristics of long-term peritoneal dialysis survivors: 18 years experience in one center. Perit Dial Int 1997; 17: 151–156.

    PubMed  Google Scholar 

  49. Maiorca R, Cancarini GC, Brunori G, Zubani R, Camerini C, Manili L, Movilli E. Comparison of long-term survival between hemodialysis and peritoneal dialysis. Adv Perit Dial 1996; 12: 79–88.

    PubMed  CAS  Google Scholar 

  50. Davies SJ, Phillips L, Griffiths AM, Russell LH, Naish PF, Russell GI. What really happens to people on long-term peritoneal dialysis? Kidney Int 1998 (Dec); 54: 2207–2217.

    Article  PubMed  CAS  Google Scholar 

  51. De Vecchi AF, Maccario M, Scalamogna A, Castelnovo C, Ponticelli C. Nine patients treated for more than 10 years with continuous ambulatory peritoneal dialysis. Am J Nephrol 1996; 16: 455–461.

    Article  PubMed  CAS  Google Scholar 

  52. Maiorca R, Cancarini GC, Zubani R, Camerini C, Manili L, Brunori G, Movilli E. CAPD viability: a long-term comparison with hemodialysis. Perit Dial Int 1996; 16: 276–287.

    PubMed  CAS  Google Scholar 

  53. Vonesh EF, Moran J. Mortality in end-stage renal disease: a reassessment of differences between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephr 1999; 10: 354–365.

    CAS  Google Scholar 

  54. US Renal Data System. USRDS 1991 Annual Data Report, the National Institute of Diabetes and Digestive and Kidney Diseases. Am J Kidney Dis 1991; 18(Suppl 2): 49–60.

    Google Scholar 

  55. Bloembergen WE, Port FK, Mauger EA, Wolfe RA. A comparison of mortality between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 1995; 6: 177–183.

    PubMed  CAS  Google Scholar 

  56. Held PJ, Port FK, Turenne N, Gaylin DS, Hamburger RJ, Wolfe RA. Continuous ambulatory peritoneal dialysis and hemodialysis: comparison of patient mortality with adjustment for comorbid conditions. Kidney Int 1994; 45: 1163–1169.

    Article  PubMed  CAS  Google Scholar 

  57. Nelson, CB, Port, FK, Wolfe, RA, Guire, KE. Comparison of continuous ambulatory peritoneal dialysis and hemodialysis patient survival with evaluation of trends during the 1980s. J Am Soc Nephrol 1992; 3: 1147–1155.

    PubMed  CAS  Google Scholar 

  58. Fenton SS, Schaubel DE, Desmeules M, Morrison HI, Mao Y, Copleston P, Jeffery JR, Kjellstrand CM. Hemodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates. Am J Kidney Dis 1997; 30: 334–342.

    Article  PubMed  CAS  Google Scholar 

  59. Collins AJ, Hao W, Xia H, et al. Mortality risks of peritoneal dialysis and hemodialysis. Am J Kidney Dis 1999; 34: 1065–1074.

    Article  PubMed  CAS  Google Scholar 

  60. Schaubel D, Fenton SSA. Trends in Mortality on Peritoneal Dialysis: Canada, 1981–1997. Journal of the American Society of Nephrology 2000; 1: 126–133.

    Google Scholar 

  61. Krishnan M, Schaubel D, Bargman MJ, Oreopoulos DG, Fenton SSA. HD versus PD in Canada Revised. Abstract, Meeting of the International Society of Peritoneal Dialysis, Montreal, June 26–28, 2001.

    Google Scholar 

  62. Murphy WS, Foley NR, Barreti JB, et al. Comparative mortality of hemodialysis and peritoneal dialysis in Canada. Kidney International 2000; 57: 1720–1726.

    Article  PubMed  CAS  Google Scholar 

  63. Strauss FG, Holmes DL, Dennis RL. Dialysis adequacy indices in high membrane transporters treated with short-dwell peritoneal dialysis. Adv Perit Dial 1995; 11: 110–113.

    PubMed  CAS  Google Scholar 

  64. Saade M, Joglar F. Chronic peritoneal dialysis: seven-year experience in a large Hispanic program. Perit Dial Int 1995; 1: 37–41.

    Google Scholar 

  65. Liberek T, Renke M, Lichodziejewska-Niemierko M, Rutkowski B. The role of Automated Peritoneal Dialysis in peritoneal dialysis programme: one centre experience. Int J Artif Organs 1999; 11: 734–738.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Toronto Western Hospital, University of Toronto, Room A44 Research Wing, Toronto, Ontario, M5T 2S8, Canada

    Dimitrios Oreopoulos M.D. (Professor of Medicine)

Authors
  1. Ploumis Passadakis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dimitrios Oreopoulos M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Downstate Medical Center, State University of New York, New York, USA

    Eli A. Friedman M.D.

  2. Colombia University, New York, USA

    Francis A. L’Esperance Jr. M.D.

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Passadakis, P., Oreopoulos, D. (2002). Long-Term Perspective on Utility of Peritoneal Dialysis in Diabetes. In: Friedman, E.A., L’Esperance, F.A. (eds) Diabetic Renal-Retinal Syndrome. Springer, Dordrecht. https://doi.org/10.1007/978-94-010-0614-9_14

Download citation

  • DOI: https://doi.org/10.1007/978-94-010-0614-9_14

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-3930-7

  • Online ISBN: 978-94-010-0614-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation